1 – 10 of 10
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
(
- Contribution to journal › Article
- 2023
-
Mark
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia
(
- Contribution to journal › Article
- 2022
-
Mark
Decreased CSF oxytocin relates to measures of social cognitive impairment in Huntington's disease patients
(
- Contribution to journal › Article
- 2021
-
Mark
Astrocytic reactivity triggered by defective autophagy and metabolic failure causes neurotoxicity in frontotemporal dementia type 3
(
- Contribution to journal › Article
- 2017
-
Mark
TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3)
(
- Contribution to journal › Article
-
Mark
Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation
(
- Contribution to journal › Article
- 2014
-
Mark
Frontotemporal dementia and its subtypes: a genome-wide association study.
(
- Contribution to journal › Article
- 2009
-
Mark
Reduced CSF CART in dementia with Lewy bodies.
(
- Contribution to journal › Article
-
Mark
A Swedish family with de novo alpha-synuclein A53T mutation: Evidence for early cortical dysfunction.
(
- Contribution to journal › Article
- 2007
-
Mark
Cocaine- and amphetamine-regulated transcript is increased in Huntington disease.
(
- Contribution to journal › Article